Your time is valuable, so we've drilled down the three most important medtech stories from the past week. But feel free to click the headline to read beyond the blurb.Image by OpenClipart-Vectors on Pixabay
As the deadline for the new medical device regulations to go into force in the European Union rapidly approaches (end of May), the European Commission (EC) is looking to postpone the new regulations by one year. The delay would allow national authorities and industry to focus on urgent priorities related to the coronavirus (COVID-19) crisis, said a spokesman for the EC.
Tweets from Elon Musk and Medtronic attracted a lot of positive and negative attention. Musk said he "had a long engineering discussion with Medtronic about state-of-the-art ventilators." Medtronic said it is grateful for the discussion with Musk and Tesla as the company works across industries to solve problems associated with the coronavirus pandemic.
Conformis is furloughing one-third of its workforce (about 80 employees) citing a sharp decline in elective procedures because of the COVID-19 pandemic. The custom orthopedics implant company also withdrew its previous 2020 product revenue growth target of 3% to 6%. Meanwhile, Obalon Therapeutics is exploring financial and strategic alternatives for the same reason. The weight-loss device maker said these alternatives could include equity or debt financing; a sale of the company; a business combination; or a merger or reverse merger with another party.